Vanda Pharmaceuticals Inc. Business Finance Contracts & Agreements
12 Contracts & Agreements
- Purchase Agreements (1 contract)
- Registration Rights Agreements (3)
- Stock Agreements (2)
- Trust Agreements (1)
- Underwriting Agreements (3)
- Warrant Agreements (2)
- Amendment No. 2 to the Rights Agreement, dated as of August 7, 2024, by and between Vanda Pharmaceuticals Inc. and Equiniti Trust Company, LLC, as rights agent (Filed With SEC on August 8, 2024)
- Amendment No. 1 to the Rights Agreement, dated as of May 3, 2024, by and between Vanda Pharmaceuticals Inc. and Equiniti Trust Company, LLC, as rights agent (Filed With SEC on May 3, 2024)
- Rights Agreement, dated as of April 17, 2024, by and between Vanda Pharmaceuticals Inc. and Equiniti Trust Company, LLC as rights agent (Filed With SEC on April 17, 2024)
- Asset Purchase Agreement, dated December 7, 2023, by and between Actelion Pharmaceuticals Ltd. and the registrant (Filed With SEC on February 8, 2024)
- Underwriting Agreement, dated March 15, 2018 by and among the Company, Citigroup Global Markets Inc. and Jefferies LLC, as representatives of the several underwriters named therein (Filed With SEC on March 16, 2018)
- STOCK PURCHASE AGREEMENT (Filed With SEC on March 13, 2015)
- 5,000,000 Shares of Common Stock par value $0.001 750,000 Option Shares Vanda Pharmaceuticals Inc. PURCHASE AGREEMENT (Filed With SEC on October 29, 2014)
- 4,680,000 Shares of Common Stock par value $0.001 702,000 Over-Allotment Shares Vanda Pharmaceuticals Inc. UNDERWRITING AGREEMENT (Filed With SEC on August 7, 2013)
- EX-1.1: FORM OF UNDERWRITING AGREEMENT (Filed With SEC on March 28, 2006)
- EX-10.10: SUMMARY PLAN DESCRIPTION PROVIDED FOR THE 401(K) PROFIT SHARING PLAN & TRUST (Filed With SEC on December 29, 2005)
- EX-4.3: CLASS A COMMON STOCK PURCHASE WARRANT (Filed With SEC on December 29, 2005)
- EX-4.2: CLASS A COMMON STOCK PURCHASE WARRANT (Filed With SEC on December 29, 2005)
